[go: up one dir, main page]

ES2074968B1 - Nuevas cepas de pseudomonas aeruginosa atenuadas. - Google Patents

Nuevas cepas de pseudomonas aeruginosa atenuadas.

Info

Publication number
ES2074968B1
ES2074968B1 ES09550003A ES9550003A ES2074968B1 ES 2074968 B1 ES2074968 B1 ES 2074968B1 ES 09550003 A ES09550003 A ES 09550003A ES 9550003 A ES9550003 A ES 9550003A ES 2074968 B1 ES2074968 B1 ES 2074968B1
Authority
ES
Spain
Prior art keywords
proteins
strain
cell wall
aeruginous
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09550003A
Other languages
English (en)
Other versions
ES2074968A1 (es
Inventor
Hyun Su Kim
Wan Je Park
Moo Sang Moon
Wang Don Yoo
Kap Soo Noh
Dong Eok Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cheil Foods and Chemicals Inc
Original Assignee
Cheil Foods and Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019930010273A external-priority patent/KR960014620B1/ko
Priority claimed from KR1019930010281A external-priority patent/KR970001710B1/ko
Application filed by Cheil Foods and Chemicals Inc filed Critical Cheil Foods and Chemicals Inc
Publication of ES2074968A1 publication Critical patent/ES2074968A1/es
Application granted granted Critical
Publication of ES2074968B1 publication Critical patent/ES2074968B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

NUEVAS CEPAS DE PSEUDOMONAS AERUGINOSA ATENUADAS Y VACUNAS PARA LA PROFILAXIS CONTRA LA INFECCION DE PSEUDOMONAS AERUGINOSA QUE COMPRENDE UNA MEZCLA DE PROTEINAS DE LA PARED CELULAR DERIVADAS, AL MENOS, DE UNA NUEVA CEPA DE PSEUDOMONAS AERUGINOSA ATENUADA, Y UN PROCEDIMIENTO PARA PREPARAR DICHA VACUNA QUE COMPRENDE: RECOGER PSEUDOMONAS AERUGINOSA DE PACIENTES INFECTADOS CON LA MISMA; SELECCIONAR Y AISLAR AL MENOS UNA ESPECIE EN ESTADO PURO; INCUBAR DICHAS ESPECIES EN UN PRIMER MEDIO DE CULTIVO; ATENUAR CADA CEPA INCUBADA Y SELECCIONAR LA CEPA MAS ATENUADA; INCUBAR CADA CEPA ATENUADA EN UN SEGUNDO MEDIO DE CULTIVO; SEPARAR LA CEPA DEL MEDIO DE CULTIVO; TRATAR LA CEPA CON DISOLVENTE ORGANICO; EXTRAER LAS PROTEINAS DE LA PARED CELULAR; SOMETER LAS PROTEINAS A ULTRAFILTRACION; ULTRACENTRIFUGAR LAS PROTEINAS, RECUPERAR LAS PROTEINAS EN UN ESTADO PURO; Y PREPARAR UNA VACUNA UTILIZANDO LAS PROTEINAS DE LA PARED CELULAR SELECCIONADAS COMO UNA SUSTANCIA ANTIGENICA. (*) 13 (DAL HYUN KIM Y 14) YOUNG GI KIM.
ES09550003A 1993-06-07 1994-06-02 Nuevas cepas de pseudomonas aeruginosa atenuadas. Expired - Fee Related ES2074968B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019930010273A KR960014620B1 (ko) 1993-06-07 1993-06-07 신규한 약독화 녹농균 및 그를 이용한 녹농균 감염 예방 백신
KR1019930010281A KR970001710B1 (ko) 1993-06-07 1993-06-07 녹농균 감염증 치료제 및 그의 제조방법

Publications (2)

Publication Number Publication Date
ES2074968A1 ES2074968A1 (es) 1995-09-16
ES2074968B1 true ES2074968B1 (es) 1996-05-01

Family

ID=26629705

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09550003A Expired - Fee Related ES2074968B1 (es) 1993-06-07 1994-06-02 Nuevas cepas de pseudomonas aeruginosa atenuadas.

Country Status (16)

Country Link
EP (1) EP0702564B1 (es)
JP (1) JP2911603B2 (es)
CN (1) CN1112356A (es)
AT (1) AT408445B (es)
AU (1) AU676575B2 (es)
CA (1) CA2141871C (es)
CH (1) CH687233A5 (es)
DE (3) DE4493997C2 (es)
ES (1) ES2074968B1 (es)
GB (1) GB2285925B (es)
NL (1) NL194910C (es)
NO (1) NO317148B1 (es)
RU (1) RU2155226C2 (es)
SE (1) SE507114C2 (es)
TW (1) TW403655B (es)
WO (1) WO1994028928A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1086588C (zh) * 1995-12-07 2002-06-26 余国华 假单胞菌活性蛋白及其生产方法
CN1328371C (zh) * 2005-09-01 2007-07-25 北京未名凯拓农业生物技术有限公司 一株铜绿假单胞菌及其培养方法与应用
CN102534027A (zh) * 2012-02-14 2012-07-04 上海中优医药高科技有限公司 MDRPA中QacEΔ1基因的检测引物及其检测方法
CN102534029A (zh) * 2012-02-14 2012-07-04 上海中优医药高科技有限公司 MRSA中QacB基因的检测引物及其检测方法
IT201600091033A1 (it) * 2016-09-08 2018-03-08 Bioimmunizer Sagl Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
CN109401992B (zh) * 2017-08-18 2021-07-23 黑龙江省科学院微生物研究所 一株高产内毒素蛋白的铜绿假单胞菌及其应用
CN110724647B (zh) * 2018-07-17 2022-11-04 黑龙江省科学院微生物研究所 一株所产内毒素蛋白对7种血清型菌株具有免疫保护作用的铜绿假单胞菌及其应用
WO2021031270A1 (zh) * 2019-08-22 2021-02-25 四川大学 细菌膜囊泡及其分离制备系统和方法
CN114763544A (zh) * 2021-01-15 2022-07-19 黑龙江省科学院微生物研究所 一种铜绿假单胞菌高产蛋白菌株的生物诱变方法
CN117940554A (zh) * 2022-06-30 2024-04-26 上海羽冠生物技术有限公司 假单胞菌属的活细菌菌株

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928565A (en) * 1971-10-19 1975-12-23 Yuzuru Homma Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties
US3987164A (en) * 1970-10-20 1976-10-19 Yuzuru Homma Method for prevention of pseudomonas aeruginosa infections
JPS5612435B1 (es) * 1971-03-29 1981-03-20
DE3829616C2 (de) * 1988-09-01 1996-08-29 Behringwerke Ag Lipoprotein I (OMPI) von Pseudomonas aeruginosa

Also Published As

Publication number Publication date
NO950421D0 (no) 1995-02-06
CH687233A5 (de) 1996-10-31
NL194910B (nl) 2003-03-03
EP0702564A1 (en) 1996-03-27
GB2285925B (en) 1997-04-09
NL194910C (nl) 2003-07-04
DE4493997C2 (de) 1997-07-17
AT408445B (de) 2001-11-26
RU2155226C2 (ru) 2000-08-27
WO1994028928A1 (en) 1994-12-22
AU6857194A (en) 1995-01-03
DE4447677C2 (de) 1998-07-23
EP0702564B1 (en) 2000-03-01
JP2911603B2 (ja) 1999-06-23
NL9420005A (nl) 1995-06-01
DE4493997T1 (de) 1995-10-05
GB9502373D0 (en) 1995-03-29
SE9500418D0 (sv) 1995-02-06
CA2141871C (en) 1999-05-11
NO950421L (no) 1995-04-07
SE507114C2 (sv) 1998-03-30
AU676575B2 (en) 1997-03-13
TW403655B (en) 2000-09-01
NO317148B1 (no) 2004-08-30
CN1112356A (zh) 1995-11-22
ATA900694A (de) 2001-04-15
GB2285925A (en) 1995-08-02
CA2141871A1 (en) 1994-12-22
JPH09501826A (ja) 1997-02-25
ES2074968A1 (es) 1995-09-16
SE9500418L (sv) 1995-04-07

Similar Documents

Publication Publication Date Title
EA200900784A1 (ru) Вакцины, включающие антиген из четырех штаммов вируса гриппа
ES2139553T1 (es) Replicacion de virus de la gripe en un cultivo de celulas de mamiferos y produccion de vacuna.
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
SE8701413D0 (sv) Expression and purification of an htlv-iii gag/env gene protein
ES2074968B1 (es) Nuevas cepas de pseudomonas aeruginosa atenuadas.
DK0891420T3 (da) Fremgangsmåde til replikation af influenzavirus i cellekultur samt de ved fremgangsmåden opnåelige influenzavirus
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
ES2129386T1 (es) Vacuna contra influenza.
Fiset Phase variation of Rickettsia (Coxiella) burneti: Study of the antibody response in guinea pigs and rabbits
ES2179105T3 (es) Adyuvantes proteinicos.
NZ334941A (en) Methods for treating infections using proteins which induce an immune response in one animal species but not in another
ES2185811T3 (es) Metodo para detectar bacterias.
PE72699A1 (es) Antigeno del rotavirus, vacuna y agente diagnostico para infeccion por rotavirus y un metodo para producir el antigeno
AU6302280A (en) Feline infectious peritonitis vaccine
Smith The transmission of a plant virus complex by aphides
ES2182847T3 (es) Nucleosidos y nucleotidos de anillo expandido.
DE69633919D1 (de) Mehrzweckvakzine gegen umhüllte viren
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
Holden The nature and properties of the virus of herpes
KR880002998A (ko) 가금류의 대장균증 백신
ES2085888T3 (es) Composicion de vacuna.
ES2080024B1 (es) Vacuna subunitaria recombinante contra la enfermedad hemorragica virica de los conejos.
ES486441A0 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
ITRM950209A1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
ES2074965B1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20180806